Cambridge Investment Research Advisors’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
|
|||||
|
2025
Q1 | $145K | Hold |
|
|||||
|
2024
Q4 | $153K | Buy |
|
|||||
|
2024
Q3 | $315K | Buy |
|
|||||
|
2024
Q2 | $253K | Sell |
|
|||||
|
2024
Q1 | $290K | Sell |
|
|||||
|
2023
Q4 | $210K | Sell |
|
|||||
|
2023
Q3 | $265K | Buy |
|
|||||
|
2023
Q2 | $193K | Sell |
|
|||||
|
2023
Q1 | $299K | Sell |
|
|||||
|
2022
Q4 | $171K | Buy |
|
|||||
|
2022
Q3 | $246K | Buy |
|
|||||
|
2022
Q2 | $195K | Buy |
|
|||||
|
2022
Q1 | $234K | Sell |
|
|||||
|
2021
Q4 | $317K | Sell |
|
|||||
|
2021
Q3 | $638K | Sell |
|
|||||
|
2021
Q2 | $539K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $402K | Sell |
|
|||||
|
2020
Q3 | $510K | Sell |
|
|||||
|
2020
Q2 | $621K | Sell |
|
|||||
|
2020
Q1 | $401K | Buy |
|
|||||
|
2019
Q4 | $545K | Sell |
|
|||||
|
2019
Q3 | $857K | Buy |
|
|||||
|
2019
Q2 | $965K | Buy |
|
|||||
|
2019
Q1 | $900K | Buy |
|